Sepsis and the kidney: New developments in pathogenesis and treatment

Turkish Nephrology, Dialysis and Transplantation Journal

Volumn 22, Issue 1, 2013, Pages 16-29

  Koçkara, Ayşe Şeker ^a   Kayataş, Mansur ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Pathophysiology; Renal failure; Sepsis

Indexed keywords

EID: 84873580386     PISSN: 13007718     EISSN: None     Source Type: Journal    
DOI: 10.5262/tndt.2013.1001.03     Document Type: Review

References (78)

1. Baskan S: Sepsis ve böbrek yetmezliǧi. ANKEM Dergisi 1999; 13 (3): 194-197
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554
3. Uzun O, AkalIn HE, Hayran M, Unal S: Factors influencing prognosis in gram-negative bacteraemia: Evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis 1992; 15: 866-873
4. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004; 351: 159-169
5. Akinci SB: Sepsis ve akut böbrek yetersizliǧi. Türk Yoǧun Bakim Derneǧi Dergisi 2010; 8 (1): 7-17
6. Bone RC: Sepsis, the sepsis syndrome, multiorgan failure: A plea for comparable definitions. Ann Intern Med 1991; 114: 332-333
7. Cohen J: The immunopathogenesis of sepsis. Nature 2002; 420: 885-891
8. Hotchkiss RS, Karl IE: The Pathophysiology and treatment of sepsis. N Engl J Med 2003; 348(2): 138-150
9. Cinel I, Dellinger R: Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 2007; 20 (4): 345-352
10. Wan L, Bellomo R, Giantomasso DD, Ronco C: The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003; 9: 496-502
11. Bone RC, Grodzin CJ, Balk RA: Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 1997; 112: 235-243
12. Karaali R, Tabak F: Sepsis patogenezi. Klinik Gelişim 2009; 22: 71-76
13. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D: Cytokine cascade in sepsis. Scand J Infect Dis 2003; 35 (9): 535-544
14. Tiwari SC, Vikrant S: Sepsis and the kidney: Review article. Journal of Indian Academy of Clinical Medicine 2000;5(1): 44-54
15. Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R: Pathophysiology of septic acute kidney injury: What do we really know? Crit Care Med 2008; 36 (4 Suppl): S198-203
16. Langenberg C, Bagshaw SM, May CN, Bellomo R: The histopathology of septic acute kidney injury: A systematic review. Crit Care 2008; 12: R38
17. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM: Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-1251
18. Rosenberg IK, Gupta SL, Lucas CE, Khan AA, Rosenberg BF: Renal insufficiency after trauma and sepsis. A prospective functional and ultrastructural analysis. Arch Surg 1971; 103: 175-183
19. Zappacosta AR, Ashby BL: Gram-negative sepsis with acute renal failure. Occurence from acute glomerulonephritis. JAMA 1977; 238: 1389-1390
20. Henkart PA: Apoptosis: O death, where is thy sting? J Immunol 1995; 154 (10): 4905-4908
21. Steller H: Mechanisms and genes of cellular suicide. Science 1995; 267 (5203): 1445-1449
22. Hetts SW: To die or not to die: An overview of apoptosis and its role in disease. JAMA 1998; 279: 300-307
23. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 1996; 87 (2): 171
24. Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424
25. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 1998; 281 (5381): 1312-1316
26. Hengardner MO: The biochemistry of apoptosis. Nature 2000; 407: 770-776
27. Ortiz A, González Cuadrado S, Lorz C, Egido J: Apoptosis in renal diseases. Front Biosci 1996; 1: 30-47
28. Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY, Won NH: Inflammatory cytokines and lipopolysaccharide induce Fasmediated apoptosis in renal tubular cells. Nephron 2002; 91: 406-415
29. Messmer UK, Briner VA, Pfeilschifter J: Tumor necrosis factoralpha and lipopolysaccharide induce apoptotik cell death in bovine glomerular endothelial cells. Kidney Int 1999; 55: 2322-2337
30. Lerolle N, Nochy D, Guérot E, Bruneval P, Fagon JY, Diehl JL, Hill G: Histopathology of septic shock induced renal injury: Apotosis and leukocytic infiltration. Intensive Care Med 2010; 36: 471-478
31. Jacobs R, Honore PM, Joannes-Boyau O, Boer W, De Regt J, De Waele E, Collin V, Spapen HD: Septic Acute Kidney Injury: The Culprit Is Inflammatory Apoptosis rather than Ischemic Necrosis. Blood Purif 2011; 32: 262-265
32. Homsi E, Janino P, de Faria JB: Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int 2006; 69: 1385-1392
33. Cantaluppi V, Assenzio B, Pasero D, Romanazzi GM, Pacitti A, Lanfranco G, Puntorieri V, Martin EL, Mascia L, Monti G, Casella G, Segoloni GP, Camussi G, Ranieri VM: Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008; 34: 1638-1645
34. Wang W, Bansal S, Falk S, Ljubanovic D, Schrier RW: Ghrelin protects mice against endotoxemia- induced acute kidney injury. Am J Physiol Renal Physiol 2009; 297: F1032-F1037
35. Simon F, Giudici R, Scheuerle A, Gröger M, Asfar P, Vogt JA, Wachter U, Ploner F, Georgieff M, Möller P, Laporte R, Radermacher P, Calzia E, Hauser B: Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: A randomized controlled trial. Crit Care 2009; 13: R113
36. Bahlmann FH, Fliser D: Erythropoietin and renoprotection. Curr Opin Nephrol Hypertens 2009; 18: 15-20
37. Jungers P, Choukroun G, Oualim Z, Robino C, Nguyen AT, Man NK: Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 2001; 16: 307-312
38. Schrier RW, Zolty E, Wang W: Sepsis and acute renal failure. In: Vincent JL, ed. Yearbook of intensive care and emergency medicine. Germany: Springer-Verlag Berlin Heidelberg 2006: 673-679
39. Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S. Renal blood flow in sepsis. Crit Care 2005; 9: 363-374
40. Cankurtaran M, Kiykim A: Sepsiste renal hemodinami ve mediyatörler. Erciyes Tip Dergisi 2002; 24: 202-208
41. Brenner M, Schaer GL, Mallory DL, Suffredini AF, Parillo JE: Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990; 98: 170-179
42. Langenberg C, Wan L, Egi M, May CN, Bellomo R: Renal blood flow and function during recovery from experimental septic acute kidney injury. Intensive Care Med 2007; 33: 1614-1618
43. Mete B: Sepsiste böbrek ve karaciǧer. Güncel Bilgiler Işiǧinda Sepsis Sempozyum Dizisi 2006; 51: 35-43
44. Knotek M, Rogachev B, Wang W, Ecder T, Melnikov V, Gengaro PE, Esson M, Edelstein CL, Dinarello CA, Schrier RW: Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 2001; 59: 2243-2249
45. Baud L, Oudinet JP, Bens M, Noe L, Peraldi MN, Rondeau E, Etienne J, Ardaillou R: Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 1989; 35: 1111-1118
46. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168: 5817-5823
47. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V: Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 2003; 289: 2104-2112
48. Jane Gaddard, Allan D Cumning: Renal alteration in the septic patients in Claudio Ronco & Rinaldo Bellmo (eds). Critical Care Nephrology Kluwer Academic Publishers, 1998; 1: 517-526
49. Anupam Agarwal, Leopoldo Raij: Endothelial dysfunction in ARF in Claudio Ronco & Rinaldo Bellmo (eds). Critical Care Nephrology Kluwer Academic Publishers 1998; 1: 527-550
50. Klenzak J, Himmelfarb J: Sepsis and the kidney. Crit Care Clin 2005; 21: 211-222
51. Lombardi R, Zampedri L, Rodriguez I, Alegre S, Ursu M, Di Fabio M: Prognosis in acute renal failure of septic origin: A Multivariate Analysis. Ren Fail 1998; 20 (5): 725-732
52. Levy B: Lactate and shock state: The metabolic view. Curr Opin Crit Care 2006; 12: 315-321
53. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, Tomlanovich MC: Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32: 1637-1634
54. Mackenzie I, Woodhouse J: C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction. Intensive Care Med 2006; 32: 1344-1351
55. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003
56. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-607
57. Luyt CE, Guérin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J: Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 48-53
58. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34: 2596-2602
59. Gibot S, Kolopp-Sarda MN, Béné MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004; 141: 9-15
60. Yapici N, Cinel I: Sepsis tedavisinde erken yaklaşimin önemi. Türk Anest Rean Der Dergisi 2007; 35 (6): 379-392
61. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-873
62. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical- Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327
63. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34 (6): 1589-1596
64. Lameire NH, De Vriese AS, Vanholder R: Prevention and nondialytic treatment of acute renal failure. Curr Opin Crit Care 2003; 9: 481-490
65. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350 (22): 2247-2256
66. Sprung CL, Anane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J; CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358 (2): 111-124
67. Montori VM, Bistrian BR, McMahon MM: Hyperglycemia in acutely ill patients. JAMA 2002; 288: 2167-2169
68. Vanhorebeek I, Van den Berghe G: Diabetes of injury: Novel insights. Endocrinol Metab Clin North Am 2006; 35: 859-872
69. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G: Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88: 1082-1088
70. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G: Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115: 2277-2286
71. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
72. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-461
73. Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MM: High glucose-induced oxidative stres causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 2003; 17: 908-910
74. Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G: Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 2008; 19 (3): 571-578
75. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356: 26-30
76. Cole L, Bellomo R, Hart G: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30: 100-106
77. Ketteler M, Cetto C, Kirdorf M, Jeschke GS, Schäfer JH, Distler A: Nitric Oxide in sepsis syndrome: Potential treatment of septic shock by nitric oxide synthase antagonists. Kidney Int Suppl 1998; 64: S27-S30
78. Anzuetto A, Beale R, Holzapfel, Ameson C: The Glaxo Wellcome International Septic shock study group. Multicentre placebo controlled double blind study of the nitric oxide synthase inhibitor 546 C 88 in patients with septic shock. Effect on resolution of shock and survival. Int Care Med 1997; 23 (Suppl): S57